Comparison of acute and chronic neurochemical effects of cocaine and cocaine cues in rhesus monkeys and rodents: Focus on striatal and cortical dopamine systems

Reviews in the Neurosciences

Volumn 19, Issue 2-3, 2008, Pages 113-128

  Bradberry, Charles W ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cocaine; Cortex; Extracellular dopamine; Nucleus accumbens; Rhesus monkey; Rodent

Indexed keywords

COCAINE; DOPAMINE;

ASSOCIATION; BRAIN CORTEX; CHRONIC DRUG ADMINISTRATION; COMPARATIVE STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG SELF ADMINISTRATION; DRUG TOLERANCE; HUMAN; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHESUS MONKEY; RODENT; SENSITIZATION;

EID: 48849116054     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVNEURO.2008.19.2-3.113     Document Type: Review

References (99)

1. Abercrombie ED, Keefe KA, DiFrischia DS, Zigmond MJ. Differential effect of stress on in vivo dopamine release in stratum, nucleus accumbens, and medial frontal cortex. J Neurochem 1989; 52: 1655-1658.
2. Adams BW, Bradberry CW, Moghaddam B. NMDA antagonist effects on striatal dopamine release: micro-dialysis studies in awake monkeys. Synapse 2002; 43: 12-18.
3. Ambre JJ, Belknap SM, Nelson J, Ruo TI, Shin SG, Atkinson A Jr. Acute tolerance to cocaine in humans. Clin Pharmacol Ther 1988; 44: 1-8.
4. Badiani A, Anagnostaras SG, Robinson TE. The development of sensitization to the psychomotor stimulant effects of amphetamine is enhanced in a novel environment. Psychopharmacology 1995; 117: 443-452.
5. Bassett JL Foote SL. Distribution of corticotropin-releasing factor-like immunoreactivity in squirrel monkey (Saimiri sciureus) amygdala. J Comp Neurol 1992; 323: 91-102.
6. Berger B, Gaspar P, Verney C. Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates. Trends Neurosci 1991; 14: 21-27 [published erratum appears in Trends Neurosci 1991; 14: 119].
7. 11C]raclopride/ positron emission tomography study in healthy men. Arch Gen Psychiatry 2006; 63: 1386-1395.
8. Bolla KI, Eldreth DA, London ED, Kiehl KA, Mouratidis M, Contoreggi C, Matochik JA, Kurian V, Cadet JL, Kimes AS. Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. NeuroImage 2003; 19: 1085-1094.
9. Bradberry CW. Acute and chronic dopamine dynamics in a nonhuman primate model of recreational cocaine use. J Neurosci 2000; 20: 7109-7115.
10. Bradberry CW, Barrett-Larimore RL, Jatlow P, Rubino SR. Impact of self-administered cocaine and cocaine cues on extracellular dopamine in mesolimbic and sensorimotor striatum in rhesus monkeys. J Neurosci 2000; 20: 3874-3883.
11. Bradberry CW Rubino SR. Phasic alterations in dopamine and serotonin release in striatum and prefrontal cortex in response to cocaine predictive cues in behaving rhesus macaques. Neuropsychopharmacology 2004; 29: 676-685.
12. Bradberry CW Rubino SR. Dopaminergic responses to self-administered cocaine in rhesus monkeys do not sensitize following high cumulative intake. Eur J Neurosci 2006; 23: 2773-2778.
13. Brown EE Fibiger HC. Cocaine-induced conditioned locomotion: absence of associated increases in dopamine release. Neuroscience 1992; 48: 621-629.
14. Castaneda E, Becker JB, Robinson TE. The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KCl and electrical stimulation evoked striatal dopamine release in vitro. Life Sci 1988; 42: 2447-2456.
15. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP. Limbic activation during cue-induced cocaine craving. Am J Psychiatry 1999; 156: 11-18.
16. 1 antagonists. Proc Natl Acad Sci USA 2001; 98: 1976-1981.
17. Cragg SJ, Hille CJ, Greenfield SA. Dopamine release and uptake dynamics within nonhuman primate striatum in vitro. J Neurosci 2000; 20: 8209-8217.
18. Cragg SJ, Hille CJ, Greenfield SA. Functional domains in dorsal striatum of the nonhuman primate are defined by the dynamic behavior of dopamine. J Neurosci 2002; 22: 5705-5712.
19. de Wit H Stewart J. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology 1981; 75: 134-143.
20. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988; 85: 5274-5278.
21. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 1995; 38: 95-137.
22. Elsworth JD, Deutch AY, Redmond DE Jr, Sladek JR Jr, Roth RH. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF. Brain Res 1987; 415: 293-299.
23. Erb S, Shaham Y, Stewart J. Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology 1996; 128: 408-412.
24. Erb S, Shaham Y, Stewart J. The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J Neurosci 1998; 18: 5529-5536.
25. Everitt BJ Wolf ME. Psychomotor stimulant addiction: a neural systems perspective. J Neurosci 2002; 22: 3312-3320.
26. Febvret A, Berger B, Gaspar P, Verney C. Further indication that distinct dopaminergic subsets project to the rat cerebral cortex: lack of colocalization with neurotensin in the superficial dopaminergic fields of the anterior cingulate, motor, retrosplenial and visual cortices. Brain Res 1991; 547: 37-52.
27. Foltin RW, Fischman MW. Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. J Pharmacol Exp Ther 1991; 257: 247-261.
28. Foltin RW Fischman MW. The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans. J Pharmacol Exp Ther 1992; 261: 623-632.
29. Frantz KJ, O'Dell LE, Parsons LH. Behavioral and neurochemical responses to cocaine in periadolescent and adult rats. Neuropsychopharmacology 2007; 32: 625-637.
30. 3 receptors in the dorsal striatum, but not in the nucleus accumbens. Eur J Pharmacol 2002; 448: 143-150.
31. Gaspar P, Berger B, Febvret A. Neurotensin innervation of the human cerebral cortex: lack of colocalization with catecholamines. Brain Res 1990; 530: 181-195.
32. Gaspar P, Berger B, Febvret A, Vigny A, Henry JP. Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-β-hydroxylase. J Comp Neurol 1989; 279: 249-271.
33. Goldstein RZ Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002; 159: 1642-1652.
34. Haber SN, Fudge JL, McFarland NR. Striatonigro-striatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci 2000; 20: 2369-2382.
35. Hammer R.Jr, Cooke ES. Gradual tolerance of metabolic activity is produced in mesolimbic regions by chronic cocaine treatment, while subsequent cocaine challenge activates extrapyramidal regions of rat brain. J Neurosci 1994; 14: 4289-4298.
36. Hammer R Jr, Egilmez Y, Emmett-Oglesby MW. Neural mechanisms of tolerance to the effects of cocaine. Behav Brain Res 1997; 84: 225-239.
37. Hyman SE. Addiction: a disease of learning and memory. Am J Psychiatry 2005; 162: 1414-1422.
38. 1A receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum. J Pharmacol Exp Ther 1999; 291: 1227-1232.
39. Invemizzi R, Garavaglia C, Samanin R. JL13, a pyridobenzoxazepine compound with potential atypical antipsychotic activity, increases extracellular dopamine in the prefrontal cortex, but not in the striatum and the nucleus accumbens of rats. Naunyn Schmiedebergs Arch Pharmacol 2000; 361: 298-302.
40. Invernizzi R, Pozzi L, Samanin R. Further studies on the effects of chronic clozapine on regional extracellular dopamine levels in the brain of conscious rats. Brain Res 1995; 670: 165-168.
41. Ito R, Dalley JW, Howes SR, Robbins TW, Everitt BJ. Dissociation in conditioned dopamine release in the nucleus accumbens core and shell in response to cocaine cues and during cocaine-seeking behavior in rats. J Neurosci 2000; 20: 7489-7495.
42. Ito R, Dalley JW, Robbins TW, Everitt BJ. Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J Neurosci 2002; 22: 6247-6253.
43. 1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat. Eur J Pharmacol 1993; 246: 39-44.
44. Jaffe JH. Drug addiction and abuse. In: Goodman LS, Gilman AG, eds. The Pharmacological Basis of Therapeutics. Elmsford: Pergamon Press, 1990; 522-573.
45. Javaid JI, Fischman MW, Schuster CR, Dekirmenjian H, Davis JM. Cocaine plasma concentration: relation to physiological and subjective effects in humans. Science 1978; 202: 227-228.
46. Kalivas PW, Duffy P. Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res 1995; 675: 325-328.
47. Kalivas PW, Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 1991; 16: 223-244.
48. Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005; 162: 1403-1413.
49. Kelley AE, Domesick VB. The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat: an anterograde- and retrograde-horseradish peroxidase study. Neuroscience 1982; 7: 2321-2335.
50. Kelley AE, Domesick VB, Nauta WJ. The amygdalostriatal projection in the rat - an anatomical study by anterograde and retrograde tracing methods. Neuroscience 1982; 7: 615-630.
51. Kimmel HL, Ginsburg BC, Howell LL. Changes in extracellular dopamine during cocaine self-administration in squirrel monkeys. Synapse 2005; 56: 129-134.
52. Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001; 24: 97-129.
53. Kuczenski R, Segal DS, Todd PK. Behavioral sensitization and extracellular dopamine responses to amphetamine after various treatments. Psychopharmacology 1997; 134: 221-229.
54. Kumor KM, Sherer MA, Gomez J, Cone E, Jaffe JH. Subjective response during continuous infusion of cocaine. Pharmacol Biochem Behav 1989; 33: 443-452.
55. Liu Y, Roberts DC, Morgan D. Sensitization of the reinforcing effects of self-administered cocaine in rats: effects of dose and intravenous injection speed. Eur J Neurosci 2005; 22: 195-200.
56. London ED, Cascella NG, Wong DF, Phillips RL, Dannals RF, Links JM, Herning R, Grayson R, Jaffe JH, Wagner H Jr. Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose. Arch Gen Psychiatry 1990; 47: 567-574.
57. Lyons D, Friedman DP, Nader MA, Porrino LJ. Cocaine alters cerebral metabolism within the ventral striatum and limbic cortex of monkeys. J Neurosci 1996; 16: 1230-1238.
58. Maisonneuve IM, Kreek MJ. Acute tolerance to the dopamine response induced by a binge pattern of cocaine administration in male rats - an in vivo microdialysis study. J Pharmacol Exp Ther 1994; 268: 916-921.
59. Marinelli M, Aouizerate B, Barrot M, Le Moal M, Piazza PV. Dopamine-dependent responses to morphine depend on glucocorticoid receptors. Proc Natl Acad Sci USA 1998; 95: 7742-7747.
60. Marinelli M, Rouge-Pont F, De Jesus-Oliveira C, Le Moal M, Piazza PV. Acute blockade of corticosterone secretion decreases the psychomotor stimulant effects of cocaine. Neuropsychopharmacology 1997; 16: 156-161.
61. Martinez D, Foltin R, Kegeles L, Hwang D, Huang Y, Hackett E, Frankle G, Laruelle M. PET imaging of dopamine transmission in the striatal substructures of humans and predictors of relapse. Soc Neurosci Abst 2003; 29: 354.
62. Montague PR, Dayan P, Sejnowski TJ. A framework for mesencephalic dopamine systems based on predictive Hebbian learning. J Neurosci 1996; 16: 1936-1947.
63. Montague PR, Hyman SE, Cohen JD. Computational roles for dopamine in behavioural control. Nature 2004; 431: 760-767.
64. Neisewander JL, O'Dell LE, Tran-Nguyen LT, Castaneda E, Fuchs RA. Dopamine overflow in the nucleus accumbens during extinction and reinstatement of cocaine self-administration behavior. Neuropsychopharmacology 1996; 15: 506-514.
65. Nobiletti JB, Jatlow PI, Bradberry CW. Differences in bioavailability between cocaine and cocaethylene and their implications for drug-reward studies. Psychopharmacology 1994; 116: 273-278.
66. Oeth KM, Lewis DA. Cholecystokinin- and dopamine-containing mesencephalic neurons provide distinct projections to monkey prefrontal cortex. Neurosci Lett 1992; 145: 87-92.
67. Pearlson GD, Jeffery PJ, Harris GJ, Ross CA, Fischman MW, Camargo EE. Correlation of acute cocaine-induced changes in local cerebral blood flow with subjective effects. Am J Psychiatry 1993; 150: 495-497.
68. Piazza PV, Le Moal M. Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Res Rev 1997; 25: 359-372.
69. Porrino LJ, Domer FR, Crane AM, Sokoloff L. Selective alterations in cerebral metabolism within the mesocorticolimbic dopaminergic system produced by acute cocaine administration in rats. Neuropsychopharmacology 1988; 1: 109-118.
70. Porrino LJ Lyons D. Orbital and medial prefrontal cortex and psychostimulant abuse: studies in animal models. Cereb Cortex 2000; 10: 326-333.
71. Richter RM, Weiss, F. In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse 1999; 32: 254-261.
72. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987; 237: 1219-1223.
73. Robbins TW, Everitt BJ. Drug addiction: bad habits add up. Nature 1999; 398: 567-570.
74. Roberts DC, Corcoran ME, Fibiger HC. On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol Biochem Behav 1977; 6: 615-620.
75. Robinson TE, Berridge KC. Addiction. Annu Rev Psychol 2003; 54: 25-53.
76. Sanchez MM, Young LJ, Plotsky PM, Insel TR. Auto-radiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. J Comp Neurol 1999; 408: 365-377.
77. Sanchez MM, Young LJ, Plotsky PM, Insel TR. Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocotticoid receptors in the hippocampal formation. J Neurosci 2000; 20: 4657-4668.
78. Schenk S, Partridge B. Sensitization and tolerance in psychostimulant self-administration. Pharmacol Biochem Behav 1997; 57: 543-550.
79. Schultz W. Predictive reward signal of dopamine neurons. J Neurophysiol 1998; 80: 1-27.
80. Segal DS, Mandell AJ. Long-term administration of damphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol Biochem Behav 1974; 2: 249-255.
81. Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immuno-reactivity for the dopamine transporter. J Neurosci 1998; 18: 2697-2708.
82. Shaham Y, Erb S, Leung S, Buczek Y, Stewart J. CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmacology 1998; 137: 184-190.
83. Shaham Y, Stewart J. Stress reinstates heroin-seeking in drug free animals: an effect mimicking heroin, not withdrawal. Psychopharmacology 1995; 119: 334-341.
84. Shou M, Ferrario CR, Schultz KN, Robinson TE, Kennedy RT. Monitoring dopamine in vivo by micro-dialysis sampling and on-line CE-laser-induced fluorescence. Anal Chem 2006; 78: 6717-6725.
85. 1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. Proc Natl Acad Sci USA 1994; 91: 5720-5724.
86. Stretch R Gerber GJ. Drug-induced reinstatement of amphetamine self-administration behaviour in monkeys. Can J Psychol 1973; 27: 168-177.
87. Vanderschuren LJ Kalivas PW. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 2000; 151: 99-120.
88. Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, Vitkun S, Logan J, Galley SJ, Pappas N, Hitzemann R, Shea CE. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 1997; 386: 827-830.
89. Volkow ND, Wang GJ, Fowler JS, Logan J, Galley SJ, Hitzemann R, Chen AD, Dewey SL, Pappas N. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997; 386: 830-833.
90. Volkow ND, Wang GJ, Telang FW, Fowler JS, Logan J, Childress AR, Jayne M, Ma Y, Wong C. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 2006; 26: 6583-6588.
91. Ward AS, Haney M, Fischman MW, Foltin RW. Binge cocaine self-administration in humans: intravenous cocaine. Psychopharmacology 1997; 132: 375-381.
92. Weiss F, Maldonado-Vlaar CS, Parsons LH, Kerr TM, Smith DL, Ben-Shahar O. Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects on recovery of extinguished operant-responding and extra-cellular dopamine levels in amygdala and nucleus accumbens. Proc Natl Acad Sci USA 2000; 97: 4321-4326.
93. Westerink BH. Brain microdialysis and its application for the study of animal behaviour. Behav Brain Res 1995; 70: 103-124.
94. Wickens JR, Reynolds JN, Hyland BI. Neural mechanisms of reward-related motor learning. Curr Opin Neurobiol 2003; 13: 685-690.
95. Widmann R Sperk G. Topographical distribution of amines and major amine metabolites in the rat striatum. Brain Res 1986; 367: 244-249.
96. Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev 1987; 94: 469-492.
97. Wise RA, Newton P, Leeb K, Burnette B, Pocock D, Justice JB. Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self administration in rats. Psychopharmacology 1995; 120: 10-20.
98. Wolf ME. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 1998; 54: 679-720.
99. Wu Q, Reith ME, Kuhar MJ, Carroll FI, Garris PA. Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission. J Neurosci 2001; 21: 6338-6347.